XPO1 AS A THERAPEUTIC TARGET IN ZFTA-RELA-DRIVEN EPENDYMOMA

$724,918FY2025Defense Health AgencyDOD

St Jude Children'S Research Hospital Inc

Investigators

View source on USAspending →